- Home
- CBFV vs NYXH Comparison
CBFV vs NYXH Comparison
Compare CBFV & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- NYXH
- Stock Information
- Founded
- CBFV 1901
- NYXH 2009
- Country
- CBFV United States
- NYXH Belgium
- Employees
- CBFV N/A
- NYXH N/A
- Industry
- CBFV Major Banks
- NYXH Medical/Dental Instruments
- Sector
- CBFV Finance
- NYXH Health Care
- Exchange
- CBFV Nasdaq
- NYXH Nasdaq
- Market Cap
- CBFV 174.9M
- NYXH 188.1M
- IPO Year
- CBFV N/A
- NYXH 2021
- Fundamental
- Price
- CBFV $34.49
- NYXH $4.60
- Analyst Decision
- CBFV Buy
- NYXH Strong Buy
- Analyst Count
- CBFV 2
- NYXH 3
- Target Price
- CBFV $36.00
- NYXH $12.67
- AVG Volume (30 Days)
- CBFV 5.7K
- NYXH 47.3K
- Earning Date
- CBFV 10-23-2025
- NYXH 11-13-2025
- Dividend Yield
- CBFV 2.98%
- NYXH N/A
- EPS Growth
- CBFV N/A
- NYXH N/A
- EPS
- CBFV 0.51
- NYXH N/A
- Revenue
- CBFV $39,329,000.00
- NYXH $6,616,215.00
- Revenue This Year
- CBFV $10.71
- NYXH $85.62
- Revenue Next Year
- CBFV $12.52
- NYXH $320.09
- P/E Ratio
- CBFV $68.57
- NYXH N/A
- Revenue Growth
- CBFV N/A
- NYXH 10.96
- 52 Week Low
- CBFV $26.01
- NYXH $4.35
- 52 Week High
- CBFV $35.37
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- CBFV 66.85
- NYXH 39.26
- Support Level
- CBFV $32.70
- NYXH $4.45
- Resistance Level
- CBFV $35.37
- NYXH $4.76
- Average True Range (ATR)
- CBFV 0.75
- NYXH 0.30
- MACD
- CBFV 0.20
- NYXH -0.04
- Stochastic Oscillator
- CBFV 91.98
- NYXH 13.25
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.